Evaluating the Effect of Ramadan Fasting on Muslim Patients with Diabetes in relation to Use of Medication and Lifestyle Patterns: A Prospective Study

Table 2

Mean daily dose of oral hypoglycemic agents and insulin at baseline.

Drug class^a; (number of patients)	Metformin; ( = 119)	Glipizide^b; ( = 70)	Sitagliptin^c; ( = 10)	Mealtime insulin; ( = 62)	Basal insulin; ( = 92)
Mean daily dose; (mg/unit)	1795.0 ± 698.4 mg	15.9 ± 9.4 mg	65.0 ± 24.2 mg	30.7 ± 24.1 units	38.1 ± 27.5 units

Values are represented as means ± SD.
^aOther oral hypoglycemic agents not included in the table were acarbose ( = 3; 100 ± 0 mg daily), pioglitazone ( = 2; 22.5 ± 10.6 mg daily), and repaglinide ( = 1; 1 ± 0 mg daily).
^bGlipizide-equivalent dose for sulfonylurea was calculated for tolbutamide, gliclazide, and glyburide [19, 20].
^cOne participant was given s-linagliptin (5 mg daily).